Who makes Oral [14C]PF-07081532?

Oral [14C]PF-07081532 is developed by Pfizer Inc..

What development phase is Oral [14C]PF-07081532 in?

Oral [14C]PF-07081532 is in Phase 1.

What is the generic name of Oral [14C]PF-07081532?

oral-14c-pf-07081532 is the generic (nonproprietary) name of Oral [14C]PF-07081532.

Last reviewed 2026-04-20 · How we verify

Oral [14C]PF-07081532 (oral-14c-pf-07081532)

Pfizer Inc. · Phase 1 active Quality 0/100

At a glance

Generic name	oral-14c-pf-07081532
Sponsor	Pfizer Inc.
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Oral [14C]PF-07081532 CI brief — competitive landscape report
Oral [14C]PF-07081532 updates RSS · CI watch RSS
Pfizer Inc. portfolio CI